Published in Neuroscience on November 01, 1997
Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis. Neurosci Biobehav Rev (2009) 1.57
Involvement of Basal Ganglia network in motor disabilities induced by typical antipsychotics. PLoS One (2009) 0.78
Fos protein expression and cocaine-seeking behavior in rats after exposure to a cocaine self-administration environment. J Neurosci (2000) 2.86
Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br J Cancer (2004) 1.63
Development of a quantitative method to analyse tumour cell invasion in organotypic culture. J Pathol (2005) 1.61
Total peripheral parenteral nutrition in pregnancy. JPEN J Parenter Enteral Nutr (1990) 1.38
Integrin alpha5beta1-mediated adenovirus infection is enhanced by the integrin-activating antibody TS2/16. J Virol (1997) 1.34
Alphavbeta6 integrin in wound healing and cancer of the oral cavity. J Oral Pathol Med (2006) 1.29
Effect of sulfonation on the cell and tissue distribution of the photosensitizer aluminum phthalocyanine. Cancer Res (1990) 1.24
AlphaVbeta6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9. Int J Cancer (2001) 1.24
Expression of the alphavbeta6 integrin promotes migration and invasion in squamous carcinoma cells. J Invest Dermatol (2001) 1.18
Methamphetamine neurotoxicity: dissociation of striatal dopamine terminal damage from parietal cortical cell body injury. Synapse (1998) 1.17
Tissue uptake, distribution, and potency of the photoactivatable dye chloroaluminum sulfonated phthalocyanine in mice bearing transplantable tumors. Cancer Res (1988) 1.15
The integrins alpha3beta1 and alpha6beta1 physically and functionally associate with CD36 in human melanoma cells. Requirement for the extracellular domain OF CD36. J Biol Chem (2000) 1.14
Cell adhesion receptor expression during melanoma progression and metastasis. Cancer Metastasis Rev (1991) 1.14
In vivo therapy of malignant melanoma by means of antagonists of alphav integrins. Int J Cancer (2000) 1.11
Running wheel exercise enhances recovery from nigrostriatal dopamine injury without inducing neuroprotection. Neuroscience (2006) 1.09
Further analysis of sensory inattention following lateral hypothalamic damage in rats. J Comp Physiol Psychol (1974) 1.09
Expression of alphav integrins and vitronectin receptor identity in breast cancer cells. Br J Cancer (1998) 1.08
Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Arch Gen Psychiatry (1992) 1.08
Identification by differential display of annexin-VI, a gene differentially expressed during melanoma progression. Cancer Res (1996) 1.07
The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments. J Cell Sci (1999) 1.06
The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells. J Cell Sci (1998) 1.06
Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists. J Neurochem (1993) 1.05
Characterizing cortical neuron injury with Fluoro-Jade labeling after a neurotoxic regimen of methamphetamine. Synapse (1998) 1.03
Functional and anatomical evidence for different dopamine dynamics in the core and shell of the nucleus accumbens in slices of rat brain. Synapse (1996) 1.02
Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Res (1991) 1.01
Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function. J Gene Med (2002) 1.01
alpha v beta 6 Integrin upregulates matrix metalloproteinase 9 and promotes migration of normal oral keratinocytes. J Invest Dermatol (2001) 1.00
Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamine. Brain Res (1992) 1.00
Sensory neglect produced by lateral hypothalamic damage. Science (1971) 0.99
A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo. Oncogene (2012) 0.99
Nigrostriatal bundle damage and the lateral hypothalamic syndrome. J Comp Physiol Psychol (1974) 0.98
Influence of tumor-derived interleukin 1 on melanoma-endothelial cell interactions in vitro. Cancer Res (1991) 0.98
Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism. Ann Neurol (1995) 0.98
Modulation of rat rotational behavior by direct gene transfer of constitutively active protein kinase C into nigrostriatal neurons. J Neurosci (1998) 0.96
Time course of adaptations in dopamine biosynthesis, metabolism, and release following nigrostriatal lesions: implications for behavioral recovery from brain injury. J Neurochem (1987) 0.96
Somatosensory inattention after dopamine-depleting intracerebral 6-OHDA injections: spontaneous recovery and pharmacological control. Brain Res (1979) 0.96
Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. Proc Natl Acad Sci U S A (1993) 0.96
Dopamine D1 receptors synergize with D2, but not D3 or D4, receptors in the striatum without the involvement of action potentials. J Neurosci (2000) 0.95
A comparison of the eating in response to hypothermic and glucoprivic challenges after nigral 6-hydroxydopamine and lateral hypothalamic electrolytic lesions in rats. Brain Res (1973) 0.94
Acceptability of fertility regulating methods: designing technology to fit people. Prev Med (1977) 0.92
Functional interaction between E-cadherin and alphav-containing integrins in carcinoma cells. J Cell Sci (2000) 0.92
Binding of TGF-beta1 latency-associated peptide (LAP) to alpha(v)beta6 integrin modulates behaviour of squamous carcinoma cells. Br J Cancer (2002) 0.92
Dopamine D-2 receptors in rat caudate-putamen: the lateral to medial gradient does not correspond to dopaminergic innervation. Brain Res (1985) 0.92
Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials. Clin Exp Metastasis (1999) 0.90
Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. Synapse (1992) 0.90
Computer-assisted video analysis of [3H]spiroperidol binding autoradiographs. J Neurosci Methods (1984) 0.90
Sensory inattention in rats with 6-hydroxydopamine-induced degeneration of ascending dopaminergic neurons: apomorphine-induced reversal of deficits. Exp Neurol (1979) 0.89
beta(3)A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in the u-PAR promoter. Mol Cell Biol (2001) 0.88
Brain dopamine and serotonin receptor sites revealed by digital subtraction autoradiography. Science (1985) 0.88
Human striatal dopamine receptors are organized in compartments. Proc Natl Acad Sci U S A (1986) 0.88
Population characteristics of preproenkephalin mRNA-containing neurons in the globus pallidus of the rat. Neurosci Lett (1999) 0.88
Photo-induced inactivation of protein kinase calpha by dequalinium inhibits motility of murine melanoma cells. Mol Pharmacol (2000) 0.88
Extracellular dopamine increases in the neonatal olfactory bulb during odor preference training. Brain Res (1991) 0.87
Hypoxia facilitates tumour cell detachment by reducing expression of surface adhesion molecules and adhesion to extracellular matrices without loss of cell viability. Br J Cancer (1998) 0.87
Further characterization of preproenkephalin mRNA-containing cells in the rodent globus pallidus. Neuroscience (2002) 0.87
Cerebrocortical Fos expression following dopaminergic stimulation: D1/D2 synergism and its breakdown. Brain Res (1996) 0.86
Striatal and cortical NMDA receptors are altered by a neurotoxic regimen of methamphetamine. Synapse (1996) 0.86
Plasticity of [14C]2-deoxy-D-glucose incorporation into neostriatum and related structures in response to dopamine neuron damage and apomorphine replacement. Brain Res (1980) 0.86
Supersensitivity to apomorphine following destruction of the ascending dopamine neurons: quantification using the rotational model. Eur J Pharmacol (1977) 0.86
Striatal dopamine and glutamate receptors modulate methamphetamine-induced cortical Fos expression. Neuroscience (2009) 0.86
The pharmacokinetics and in vitro cyclooxygenase selectivity of deracoxib in horses. J Vet Pharmacol Ther (2011) 0.86
Movement disorders of aged rats: reversal by dopamine receptor stimulation. Science (1979) 0.85
Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study. J Neurosci (1994) 0.85
Psoriasin (S100A7) associates with integrin β6 subunit and is required for αvβ6-dependent carcinoma cell invasion. Oncogene (2010) 0.85
Photodynamic therapy of a murine tumor following sensitisation with chloro aluminum sulfonated phthalocyanine. Photochem Photobiol (1987) 0.85
Recovery of function after mesotelencephalic dopaminergic injury in senescence. Brain Res (1983) 0.84
Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury. Brain Res (1984) 0.84
Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain. Synapse (1990) 0.84
Effect of tumour location on selective uptake and retention of phthalocyanines. Cancer Lett (1989) 0.84
Effect of photodynamic therapy on anti-tumor immune defenses: comparison of the photosensitizers hematoporphyrin derivative and chloro-aluminum sulfonated phthalocyanine. Photochem Photobiol (1989) 0.83
Further analysis of the resistance of the diabetic rat to d-amphetamine. Pharmacol Biochem Behav (1978) 0.83
Striatal topography of D-2 receptors correlates with indexes of cholinergic neuron localization. Neurosci Lett (1985) 0.83
MK-801 prevents methamphetamine-induced striatal dopamine damage and reduces extracellular dopamine overflow. Ann N Y Acad Sci (1992) 0.83
Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol. J Pharmacol Exp Ther (1985) 0.83
Plasticity of neostriatal dopamine receptors after nigrostriatal injury: relationship to recovery of sensorimotor functions and behavioral supersensitivity. Brain Res (1982) 0.83
Striosomal organization of cholinergic and dopaminergic uptake sites and cholinergic M1 receptors in the adult human striatum: a quantitative receptor autoradiographic study. Brain Res (1990) 0.83
Amphetamine- and cocaine-induced fos in the rat striatum depends on D2 dopamine receptor activation. Synapse (1994) 0.83
Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists. Behav Brain Res (1990) 0.82
Sensorimotor disturbances in the aging rodent. J Gerontol (1982) 0.82
The role of dopamine in the maintenance and breakdown of D1/D2 synergism. Brain Res (1993) 0.82
Increased orientation to sensory stimuli following medial hypothalamic damage in rats. Brain Res (1975) 0.82
Olfactory deprivation increases dopamine D2 receptor density in the rat olfactory bulb. Synapse (1991) 0.82
Cortical ionotropic glutamate receptor antagonism protects against methamphetamine-induced striatal neurotoxicity. Neuroscience (2011) 0.81
The protrusive phase and full development of integrin-dependent adhesions in colon epithelial cells require FAK- and ERK-mediated actin spike formation: deregulation in cancer cells. Neoplasia (2001) 0.81
Photosensitising activity of phthalocyanine dyes screened against tissue culture cells. Photochem Photobiol (1987) 0.81
L-dopa pretreatment potentiates striatal dopamine overflow and produces dopamine terminal injury after a single methamphetamine injection. Brain Res (1993) 0.81
Repeated administration of methamphetamine damages cells in the somatosensory cortex: overlap with cytochrome oxidase-rich barrels. Synapse (2000) 0.81
Evaulation of the potency of antipertussis serum products. J Biol Stand (1979) 0.81
MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow. Synapse (1992) 0.81
Activation-induced restoration of sensorimotor functions in rats with dopamine-depleting brain lesions. J Comp Physiol Psychol (1976) 0.81
Alpha v beta 6 integrin down-regulates the MMP-13 expression in oral squamous cell carcinoma cells. Exp Cell Res (2005) 0.81
Activation status and function of the VLA-4 (alpha4beta1) integrin expressed on human melanoma cell lines. Int J Cancer (1997) 0.81
Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia. Neuropsychopharmacology (1992) 0.80
Altered succinate dehydrogenase activity of basal ganglia following to mesotelencephalic dopaminergic projection. Brain Res (1981) 0.80
Apomorphine-induced restoration of drinking to thirst challenges in 6-hydroxydopamine-treated rats. Physiol Behav (1976) 0.80
MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: an in vivo microdialysis study. Brain Res (1991) 0.80
Unilateral frontal cortex ablation producing neglect causes time-dependent changes in striatal glutamate receptors. Behav Brain Res (1996) 0.79
Neostriatal dopamine uptake and reversal of age-related movement disorders with dopamine-uptake inhibitors. Ann N Y Acad Sci (1988) 0.79
Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: autoradiographic evidence against the dual mechanism hypothesis. Neuroscience (1991) 0.79